Skuldtech is an innovative biotechnology company specialized in the discovery of genomic biomarkers and the development of new diagnostic tests.
Skuldtech is involved in several national and international research programs funded by the European Union and other funding partners. These programs are focused on the identification of biomarkers, the development of diagnosis tools and innovative therapeutics.
The objective of the company is to construct a biomarker and product portfolio as well as technological intellectual property pipeline. Validated biomarkers will either be out-licensed or used in-house for final products.
To obtain more information concerning the expertises of the company associated with Biomarkers and Diagnostics, please download the document "Skuldtech expertises".
If you require any additional information concerning our company, please contact our corporate department: +33(0)467 419 748.
Skuldtech is specialized in the discovery of
Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide
genomic, pharmacogenomic and transcriptomic services,
as well as innovative diagnostics
associated with new
therapeutics especially in
cancer, rare diseases and
infectious diseases.